Gp130 Promotes Inflammation via the STAT3/JAK2 Pathway in Allergic Conjunctivitis
Investigative Opthalmology & Visual Science · 06.04.2023 · 64 (4) · 5
DOI: 10.1167/iovs.64.4.5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Opthalmology & Visual Science, erschienen am 06.04.2023. Verfasst von Jiayu Bao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Institute of Ophthalmology, Beijing TongRen Eye Center, Beijing Key Laboratory of Ophthalmology and Visual Sciences, Beijing Tongren Hospital…. Hauptthemen laut MEDLINE: Conjunctivitis, Allergic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Beijing Institute of Ophthalmology, Beijing TongRen Eye Center, Beijing Key Laboratory of Ophthalmology and Visual Sciences, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
- Department of Ophthalmology, the Second Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Inner Mongolia, China.
Zitieren
APA
Bao, J., Zhang, P., Wu, B., Wang, J., Li, S., Li, A., & Jie, Y. (2023). Gp130 Promotes Inflammation via the STAT3/JAK2 Pathway in Allergic Conjunctivitis. Investigative Opthalmology & Visual Science, 64(4), 5. https://doi.org/10.1167/iovs.64.4.5
Vancouver
Bao J, Zhang P, Wu B, Wang J, Li S, Li A, et al. Gp130 Promotes Inflammation via the STAT3/JAK2 Pathway in Allergic Conjunctivitis. Investigative Opthalmology & Visual Science. 2023;64(4):5. doi:10.1167/iovs.64.4.5
BibTeX
@article{Bao2023,
author = {Bao, Jiayu and Zhang, Peng and Wu, Binge and Wang, Jingyi and Li, Siyuan and Li, Ao and Jie, Ying},
title = {Gp130 Promotes Inflammation via the STAT3/JAK2 Pathway in Allergic Conjunctivitis},
journal = {Investigative Opthalmology & Visual Science},
year = {2023},
volume = {64},
number = {4},
pages = {5},
doi = {10.1167/iovs.64.4.5}
}
EUVIMED